Opportunity Information: Apply for RFA IP 11 014
Apply for RFA IP 11 014
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Influenza and Other Respiratory Diseases in Southern Hemisphere" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 14, 2011 and posted on Feb 10, 2011.
- Applicants must submit their applications by Mar 17, 2011 FOA Modified to Added Summary of Potential Applicant Conference Call held January 19, 2011.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education Nonprofits (Other than Institutions of Higher Education) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American tribal organizations (other than Federally recognized tribal governments) Faith based or Community based Organizations Regional Organizations Non domestic (non U.S.) Entities (Foreign Organizations) Bona Fide Agents A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Non domestic (non U.S.) Entities (Foreign Organizations) are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through the National Center for Immunization and Respiratory Diseases (NCIRD) and its Influenza Division, offered this discretionary funding opportunity to support research and data-collection activities focused on influenza and other respiratory diseases in the southern hemisphere. The award mechanism is a cooperative agreement, which typically means CDC expects substantial involvement beyond standard grant oversight, often including collaboration on study design, data standards, technical guidance, and coordination around public health priorities. The core goal is to build and support established, high-quality systems and studies in southern hemisphere locations that can generate timely evidence on how influenza and other important respiratory pathogens behave, how much illness they cause, who is at greatest risk of severe outcomes, and which prevention strategies work best.
A central rationale for the program is seasonal timing. Many southern hemisphere countries experience their influenza season during the northern hemisphere summer, when northern hemisphere surveillance and study sites are often outside peak activity. Because of this offset, southern hemisphere partners can provide critical, real-time information on circulating strains, disease burden, transmission patterns, and the real-world performance of vaccines and other interventions at a time when comparable northern hemisphere data may be limited. The opportunity also notes that other respiratory diseases may follow different seasonal patterns in the southern hemisphere compared with the north, creating additional value in studying multiple respiratory pathogens rather than influenza alone. The 2009 influenza pandemic is highlighted as a key lesson: the pandemic strain emerged just before the southern hemisphere season, underscoring the importance of having surveillance and research systems already in place to rapidly measure impact, understand transmission, and inform response decisions.
The research topics emphasized in the announcement include measuring disease burden (how much illness, hospitalization, and potentially death influenza and other priority respiratory pathogens cause), describing epidemiology (who gets infected, where, and when), characterizing transmission (how the virus spreads in communities and settings), identifying risk factors for severe illness (such as age groups, underlying conditions, pregnancy, or other vulnerabilities), and evaluating prevention strategies. Prevention is framed broadly, with explicit interest in both vaccine effectiveness and the effectiveness of other measures, which could include non-pharmaceutical interventions, clinical practices, or public health strategies that reduce spread and severe outcomes. A major expected benefit is that better understanding of influenza epidemiology and annual vaccine effectiveness in southern hemisphere settings will inform influenza control strategies globally, not only locally, because the resulting evidence can help refine vaccine policy, preparedness planning, and intervention choices in other regions.
Administratively, the opportunity is identified as RFA IP 11 014 under CFDA 93.283 (CDC Investigations and Technical Assistance). CDC anticipated making 2 awards, with an estimated total funding amount of $1,000,000 and an award ceiling of $1,000,000; the award floor is listed as $0, indicating no minimum specified in the summary. No cost sharing or matching requirement was included. The opportunity was posted on February 10, 2011, created March 14, 2011, originally closed March 14, 2011, and the closing date was extended to March 17, 2011. The record notes the FOA was modified to add a summary of a potential applicant conference call held January 19, 2011, and the archive date is April 13, 2011.
Eligibility was broad and intentionally inclusive to allow a wide range of capable organizations to participate, including higher education institutions (public and private), nonprofit organizations, and many levels of government. The eligible government categories listed include state, county, city or township, special district, tribal governments (federally recognized and other than federally recognized), eligible federal agencies, and U.S. territories or possessions. Other eligible applicants include independent school districts, public housing authorities/Indian housing authorities, native American tribal organizations (other than federally recognized tribal governments), faith-based and community-based organizations, regional organizations, bona fide agents, and non-domestic (non-U.S.) entities, meaning foreign organizations were explicitly eligible. The eligibility section also encourages applications from institutions such as Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian-serving institutions. For applicants applying as a bona fide agent of a state or local government, the announcement specifies that a legal, binding agreement documenting that status must be provided with the application.
For support related to accessing the full announcement, the CDC Procurement and Grants Office is listed as the point of contact, with TIMS phone number 770-488-2700 and email PGOTIM@cdc.gov. Overall, the opportunity is best understood as an effort to strengthen and leverage southern hemisphere research capacity to deliver seasonally timely, globally relevant evidence on influenza and other respiratory diseases, especially evidence that can improve understanding of strain circulation, public health impact, and the real-world effectiveness of vaccines and other prevention tools.
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This discretionary CDC funding opportunity supports research and data-collection activities focused on influenza and other important respiratory diseases in southern hemisphere locations. The aim is to strengthen and support established, high-quality systems and studies that can generate timely evidence on how these pathogens behave, the amount of illness they cause, who is at greatest risk for severe outcomes, and which prevention strategies work best.
Which CDC program is offering the opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC) through the National Center for Immunization and Respiratory Diseases (NCIRD) and its Influenza Division.
What type of award mechanism is used?
The award mechanism is a cooperative agreement. This typically means CDC expects substantial involvement beyond standard grant oversight, often including collaboration on study design, data standards, technical guidance, and coordination around public health priorities.
Why is the southern hemisphere specifically emphasized?
Many southern hemisphere countries experience influenza season during the northern hemisphere summer, when northern hemisphere surveillance and study sites are often outside peak activity. Because of this seasonal offset, southern hemisphere partners can provide real-time information on circulating strains, disease burden, transmission patterns, and real-world performance of vaccines and other interventions when comparable northern hemisphere data may be limited.
Does the opportunity focus only on influenza?
No. While influenza is central, the opportunity also supports work on other respiratory diseases. The announcement notes that other respiratory diseases may follow different seasonal patterns in the southern hemisphere compared with the north, which adds value in studying multiple respiratory pathogens rather than influenza alone.
What is the main goal of the program?
The core goal is to build and support established, high-quality systems and studies in southern hemisphere locations to generate timely evidence about influenza and other important respiratory pathogens, including their epidemiology, transmission, burden, risk factors for severe disease, and the effectiveness of prevention strategies.
What kinds of research topics are emphasized?
Emphasized topics include measuring disease burden (illness, hospitalization, and potentially death), describing epidemiology (who gets infected, where, and when), characterizing transmission (how viruses spread in communities and settings), identifying risk factors for severe illness (including age, underlying conditions, pregnancy, and other vulnerabilities), and evaluating prevention strategies.
What does "disease burden" mean in this announcement?
In this context, disease burden refers to how much illness influenza and other priority respiratory pathogens cause, including outcomes such as cases of illness, hospitalizations, and potentially deaths.
What does "epidemiology" mean in the context of this opportunity?
Here, epidemiology refers to describing patterns of infection and illness, including who gets infected, where infections occur, and when they occur over time.
What does "transmission" mean in the context of this opportunity?
Transmission refers to how influenza and other respiratory pathogens spread in communities and specific settings.
What risk factors for severe illness are mentioned?
The announcement highlights examining risk factors such as age groups, underlying health conditions, pregnancy, and other vulnerabilities associated with severe outcomes.
What prevention strategies are of interest?
Prevention is framed broadly. The opportunity explicitly includes interest in vaccine effectiveness and also the effectiveness of other measures, which could include non-pharmaceutical interventions, clinical practices, or public health strategies that reduce spread and severe outcomes.
How is vaccine effectiveness addressed?
The opportunity emphasizes improving understanding of influenza epidemiology and annual vaccine effectiveness in southern hemisphere settings, with the expectation that this evidence can help inform influenza control strategies globally.
How can results from southern hemisphere studies be useful outside the southern hemisphere?
The opportunity anticipates that evidence from southern hemisphere settings can inform influenza control strategies globally by improving vaccine policy, preparedness planning, and choices about interventions in other regions.
What lesson from the 2009 influenza pandemic is mentioned?
The 2009 influenza pandemic is cited as a key lesson because the pandemic strain emerged just before the southern hemisphere season. This underscores the importance of having surveillance and research systems already in place to rapidly measure impact, understand transmission, and inform response decisions.
What is the funding opportunity number and CFDA number?
The opportunity is identified as RFA IP 11 014 under CFDA 93.283 (CDC Investigations and Technical Assistance).
How many awards were anticipated?
CDC anticipated making 2 awards.
What was the estimated total funding amount?
The estimated total funding amount was $1,000,000.
What is the award ceiling?
The award ceiling is $1,000,000.
What is the award floor?
The award floor is listed as $0, meaning no minimum amount is specified in the summary.
Is cost sharing or matching required?
No cost sharing or matching requirement was included.
When was the opportunity posted and when did it close?
The opportunity was posted on February 10, 2011. It originally closed March 14, 2011, and the closing date was extended to March 17, 2011.
When was the opportunity created and when was it archived?
The record indicates it was created March 14, 2011, and the archive date is April 13, 2011.
Was the FOA modified after posting?
Yes. The record notes the FOA was modified to add a summary of a potential applicant conference call held January 19, 2011.
Who was eligible to apply?
Eligibility was broad and included higher education institutions (public and private), nonprofit organizations, and many levels of government. Eligible government categories included state, county, city or township, special district, tribal governments (federally recognized and other than federally recognized), eligible federal agencies, and U.S. territories or possessions.
Are foreign (non-U.S.) organizations eligible?
Yes. Non-domestic (non-U.S.) entities were explicitly eligible, meaning foreign organizations could apply.
What other types of organizations were listed as eligible?
Other eligible applicants included independent school districts, public housing authorities/Indian housing authorities, Native American tribal organizations (other than federally recognized tribal governments), faith-based and community-based organizations, regional organizations, bona fide agents, and non-domestic entities.
Does the opportunity encourage applications from specific types of institutions?
Yes. The eligibility section encourages applications from Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian-serving institutions.
What is required if applying as a bona fide agent of a state or local government?
The announcement specifies that a legal, binding agreement documenting bona fide agent status must be provided with the application.
Who is the point of contact for support accessing the full announcement?
The CDC Procurement and Grants Office is listed as the point of contact.
What contact details are provided for the point of contact?
The TIMS phone number is 770-488-2700 and the email address is PGOTIM@cdc.gov.
What is the overall purpose of this opportunity in practical terms?
Overall, it is an effort to strengthen and leverage southern hemisphere research capacity to deliver seasonally timely, globally relevant evidence on influenza and other respiratory diseases, including evidence that can improve understanding of strain circulation, public health impact, and the real-world effectiveness of vaccines and other prevention tools.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Distance Education Grants for Insular Areas (DEG)
Previous opportunity: Studies at the Animal Human Interface of Influenza and Other Zoonotic Diseases in Vietnam
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 11 014
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 11 014) also looked into and applied for these:
| Funding Opportunity |
|---|
| Campus Suicide Prevention Grants Apply for SM 11 002 Funding Number: SM 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $102,000 |
| Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention Apply for SM 11 001 Funding Number: SM 11 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $480,000 |
| Cooperative Agreement with the Catholic Relief Services (CRS) Apply for CDC RFA GH11 11104 Funding Number: CDC RFA GH11 11104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India Apply for RFA IP 11 012 Funding Number: RFA IP 11 012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Influenza Vaccine Efficacy in Tropical and Developing Countries Apply for RFA IP 11 013 Funding Number: RFA IP 11 013 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantee Sites Apply for HRSA 11 101 Funding Number: HRSA 11 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Sustainable Responses for Improving the Lives of Vulnerable Children and their Households Apply for RFA 617 11 000001 Funding Number: RFA 617 11 000001 Agency: Uganda USAID Kampala Category: Health Funding Amount: $29,500,000 |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Apply for PA 11 087 Funding Number: PA 11 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Apply for PA 11 088 Funding Number: PA 11 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Apply for PA 11 089 Funding Number: PA 11 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NHLBI Investigator Initiated Resource Related Research Projects (R24) Apply for PAR 11 090 Funding Number: PAR 11 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Access to Emergency Devices Apply for HRSA 11 088 Funding Number: HRSA 11 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Emerging Infections Sentinel Network (EISN) Research Apply for RFA CK 11 002 Funding Number: RFA CK 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $407,000 |
| Effectiveness in an Intervention to Promote a Targeted Vaccination Program in the Obstetrician Gynecologist Setting Apply for RFA IP 11 009 Funding Number: RFA IP 11 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| National Center for Chronic Disease Prevention and Health Promotion Conference Support Program Apply for CDC RFA DP11 1102 Funding Number: CDC RFA DP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Genomic Resource Grants for Community Resource Projects (U41) Apply for PAR 11 095 Funding Number: PAR 11 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhanced Surveillance for New Vaccine Preventable Disease Apply for RFA IP 11 010 Funding Number: RFA IP 11 010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Affordable Care Act Health Center Planning Grants Apply for HRSA 11 021 Funding Number: HRSA 11 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States Apply for RFA IP 11 003 Funding Number: RFA IP 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $785,000 |
| Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools. Apply for RFA IP 11 006 Funding Number: RFA IP 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 11 014", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.